Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-105905·Sporos Bioventures LLC
Schedule 13G ownership disclosure
CARA THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 140755208
Event date: 2025-04-15
- Filing-level shares
- 837,636
- Percent of class
- 8.95%
- Sporos Bioventures LLC
Shares: 837,636 · Class: 8.95%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-105905
- Form type
- SCHEDULE 13G
- Filer
- Sporos Bioventures LLC
- CIK
- CIK 2072022
- Filed
- Aug 08, 2025
- Reporting period
- Apr 15, 2025
- Description
- Schedule 13G beneficial ownership